<DOC>
	<DOCNO>NCT00784953</DOCNO>
	<brief_summary>A non-interventional study explore actual asthma control status real-life environment observe efficacy stepped-up Symbicort SMART various identical regimen . The study implement screen asthmatic patient respiratory clinic identify optimally control require step controller initiate , titrate dose , ICS/LABA include Symbicort .</brief_summary>
	<brief_title>Real Life Effectiveness Patients With Not Optimally Controlled Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Budesonide , Formoterol Fumarate Drug Combination</mesh_term>
	<criteria>Asthma patient partly control uncontrolled previous controller ICS , low dose ICS plus either LABA , leukotriene modifier theophylline ; ICS na√Øve severe persist symptom base physician 's judgment According GINA guideline , need step controller medication , ICS/LABA prescribe base physician 's discretion Patients age within limitation refer label information various product prescribe Patients take oral corticosteroid within 4 week prior enrollment Patients contraindication prescribed medication</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Symbicort SMART</keyword>
	<keyword>budesonide</keyword>
	<keyword>formoterol</keyword>
	<keyword>ICS/LABA</keyword>
	<keyword>Asthma Control Questionnaire</keyword>
	<keyword>Not optimally control asthma</keyword>
</DOC>